Related Experiment Video
Updated: Mar 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 isoforms change p53 paradigm
1University of Dundee; College of Medicine; Division of Cancer Research; Dundee Cancer Centre ; Dundee, United Kingdom.
Abstract:
Although p53 defines cellular responses to cancer treatment it is not clear how p53 can be used to control cell fate outcome. Data demonstrate that so-called p53 does not exist as a single protein, but is in fact a group of p53 protein isoforms whose expression can be manipulated to control the cellular response to treatment.
Insights
The p53 protein is actually a group of isoforms. Manipulating these p53 isoforms allows for control over cellular responses to cancer treatments and cell fate outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The tumor suppressor protein p53 is crucial in mediating cellular responses to cancer therapy.
- However, the precise mechanisms by which p53 influences cell fate decisions following treatment remain incompletely understood.
Purpose of the Study:
- To investigate the nature of p53 in cellular responses to cancer treatment.
- To determine if p53 can be therapeutically manipulated to control cell fate outcomes.
Main Methods:
- Analysis of p53 protein expression.
- Manipulation of p53 isoform expression levels.
- Assessment of cellular responses to various cancer treatments.
Main Results:
- p53 does not function as a single protein entity.
- p53 exists as a group of distinct protein isoforms.
- Differential expression of p53 isoforms can be modulated.
- Modulation of p53 isoform expression dictates cellular fate in response to treatment.
Conclusions:
- The p53 protein family, comprising multiple isoforms, offers a novel target for controlling cancer treatment efficacy.
- Understanding and manipulating p53 isoform expression presents a promising strategy for directing cell fate and improving therapeutic outcomes in cancer.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

